IN DATA

Powered by 

Deals analysis

Rankings

Economic data

Macro-economic indicators

INSIDE THE DEAL

Imcyse closes €21.3m Series B funding round

Imcyse has secured funding to continue developing novel immunotherapies for severe autoimmune diseases

Deals Analysis

Oncology sector leads the pack in deals volume 

The therapy area has shown strong growth, with 1,249 deals reported so far this year

Rankings

Who's leading in Europe in terms of R&D expenditure

Our pharma industry key list brings you the 15 leading biopharma companies in Europe by R&D expenditure

Deals analysis

Rankings

Economic data

Macro-economic indicators

02/24/2024 07:38:59
  • Home | Time for UK plasma to shine
  • In this issue
  • Contents
  • Datwyler
  • Labcorp
  • UPS Healthcare Company Insight
  • UPS Healthcare
  • Baxter
  • SHL Medical
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Mimotopes Company Insight
  • Mimotopes
  • PerkinElmer
  • Comment
  • A new day for Alzheimer’s disease treatment
  • Covid-19 vaccine inequity: the debate over patent waivers intensifies
  • Covid-19 vaccines show efficacy in adolescents
  • International pharmacovigilance for biotechs: forming a strategy
  • Nipro
  • HOF Sonderanlagenbau
  • Myonex
  • In Depth
  • Malaria vaccines through the ages
  • Are competition authorities tightening the rules on pharma M&A?
  • The fishy business of shark squalene
  • Without a trace: can pharma reduce scarring?
  • Blood plasma production: OK for the UK?
  • When the drugs don’t work: can pharma keep up with mental health?
  • The Solubility Company - Company Insight
  • The Solubility company
  • Owen Mumford Company Insight
  • Owen Mumford
  • In Data
  • Deals analysis
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
06/18/2021 00:00:00